DESIGN OF A PHASE III, DOUBLE-BLIND, RANDOMIZED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF ALLOGENEIC STEM CELLS (DARVADSTROCEL) FOR THE TREATMENT OF COMPLEX PERIANAL FISTULA(S) IN PATIENTS WITH CROHN'S DISEASE (ADMIRE-CD II TRIAL).

被引:0
|
作者
Wexner, S.
Sandborn, W.
Panes, J.
Gilaberte, I.
Gulati, P.
Zhang, B.
Pfeifer, J.
Garcia-Olmo, D.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P1158
引用
收藏
页码:E300 / E300
页数:1
相关论文
共 50 条
  • [21] The efficacy and safety of keverprazan in treatment of duodenal ulcer: A phase III, randomized, double-blind, multicentre trial
    Tan, Niandi
    Miao, Xin-Pu
    Liao, Ai-Jun
    Liu, Cheng-Xia
    Wu, Hao
    Chen, Hong-Hui
    Li, Fang-Fang
    Guo, Qing-Hong
    Li, Sheng-Bao
    Tang, Yan-Ping
    Xia, Min
    Liu, You-Li
    Li, Xing
    Chen, Hui-Xin
    Liu, Xiao-Wei
    Zhang, Yan
    Zhang, Zhen-Yu
    Chen, Min-Hu
    Xiao, Ying-Lian
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 38 - 39
  • [22] The efficacy and safety of keverprazan in treatment of duodenal ulcer: A phase III, randomized, double-blind, multicentre trial
    Tan, Niandi
    Miao, Xin-Pu
    Liao, Ai-Jun
    Liu, Cheng-Xia
    Wu, Hao
    Chen, Hong-Hui
    Li, Fang-Fang
    Guo, Qing-Hong
    Li, Sheng-Bao
    Tang, Yan-Ping
    Xia, Min
    Liu, You-Li
    Li, Xing
    Chen, Hui-Xin
    Liu, Xiao-Wei
    Zhang, Yan
    Zhang, Zhen-Yu
    Chen, Min-Hu
    Xiao, Ying-Lian
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 38 - 39
  • [23] Tacrolimus (FK506) for the treatment of perianal and enterocutaneous fistulas in patients with Crohn's disease: A randomized, double-blind, placebo-controlled trial
    Sandborn, WJ
    Present, DH
    Isaacs, KL
    Wolf, DC
    Greenberg, E
    Hanauer, SB
    Feagan, BG
    Johnson, T
    Joseph, G
    Martin, CF
    Sandler, RS
    GASTROENTEROLOGY, 2002, 122 (04) : A81 - A81
  • [24] A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia
    Hiroyoshi Ohta
    Hiroshi Oka
    Chie Usui
    Masayuki Ohkura
    Makoto Suzuki
    Kusuki Nishioka
    Arthritis Research & Therapy, 14
  • [25] A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia
    Ohta, Hiroyoshi
    Oka, Hiroshi
    Usui, Chie
    Ohkura, Masayuki
    Suzuki, Makoto
    Nishioka, Kusuki
    ARTHRITIS RESEARCH & THERAPY, 2012, 14 (05)
  • [26] Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn’s disease: results from a multicenter phase I/IIa clinical trial
    F. de la Portilla
    F. Alba
    D. García-Olmo
    J. M. Herrerías
    F. X. González
    A. Galindo
    International Journal of Colorectal Disease, 2013, 28 : 313 - 323
  • [27] Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I/IIa clinical trial
    de la Portilla, F.
    Alba, F.
    Garcia-Olmo, D.
    Herrerias, J. M.
    Gonzalez, F. X.
    Galindo, A.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2013, 28 (03) : 313 - 323
  • [28] Safety and efficacy of injection of human placenta mesenchymal stem cells derived exosomes for treatment of complex perianal fistula in non-Crohn's cases: Clinical trial phase I
    Pak, Haleh
    Hadizadeh, Alireza
    Heirani-Tabasi, Asieh
    Soleimani, Masoud
    Asbagh, Reza Akbari
    Fazeli, Mohammad Sadegh
    Kazemeini, Alireza
    Keshvari, Amir
    Keramati, Mohammad Reza
    Salahshour, Faezeh
    Nazari, Hengameh
    Tafti, Seyed Mohsen Ahmadi
    Behboudi, Behnam
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 (04) : 539 - 547
  • [29] Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, PlaceboControlled Clinical Trial
    Tompkins, Bryon A.
    DiFede, Darcy L.
    Khan, Aisha
    Landin, Ana Marie
    Schulman, Ivonne Hernandez
    Pujol, Marietsy V.
    Heldman, Alan W.
    Miki, Roberto
    Goldschmidt-Clermont, Pascal J.
    Goldstein, Bradley J.
    Mushtaq, Muzammil
    Levis-Dusseau, Silvina
    Byrnes, John J.
    Lowery, Maureen
    Natsumeda, Makoto
    Delgado, Cindy
    Saltzman, Russell
    Vidro-Casiano, Mayra
    Da Fonseca, Moisaniel
    Golpanian, Samuel
    Premer, Courtney
    Medina, Audrey
    Valasaki, Krystalenia
    Florea, Victoria
    Anderson, Erica
    El-Khorazaty, Jill
    Mendizabal, Adam
    Green, Geoff
    Oliva, Anthony A.
    Hare, Joshua M.
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2017, 72 (11): : 1513 - 1521
  • [30] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF CHIGLITAZAR IN NASH PATIENTS
    You, Hong
    Sun, Yameng
    Wu, Cuisong
    Xin, Guijie
    Zhong, Bihui
    Wu, Xiaofeng
    Liu, Yali
    Shi, Junping
    Zhang, Qin
    Zhao, Yingren
    Gao, Yufeng
    Xin, Yongning
    Zhu, Yueyong
    Wu, Lixian
    Mao, Xiaorong
    Du, Jian
    Shang, Jia
    Sun, Weiwei
    Xu, Jie
    Yu, Zujiang
    Nan, Yuemin
    Sheng, Huiping
    Li, Yue
    Rao, Huiying
    Yu, Chaohui
    Wu, Xiaoning
    Tong, Xiaofei
    HEPATOLOGY, 2024, 80 : S1969 - S1970